Abstract
CT025 - NMS-03592088, a novel, potent FLT3, KIT and CSF1R inhibitor with activity in FLT3 positive acute myeloid leukemia patients with prior FLT3 inhibitor experience
3 products
3 drugs
1 indication
3 targets
Indication
Acute Myeloid LeukemiaProduct
NMS-088Product
midostaurinProduct
GilteritinibDrug
NMS-088Drug
GilteritinibDrug
midostaurinTarget
FLT3Target
KITTarget
CSF1R